Clinical trial

Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction

NCT07621380

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-07-01

PhasePHASE4

Study timeline

Study start (estimated)2026-07-01Date precision: day

Registry last updated2026-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus Myocardial Infarctionunresolved

Interventions

Ertugliflozin 10 mgDRUG

Standard AMI CareOTHER

Sponsors & collaborators

Shanghai Zhongshan Hospitallead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07621380 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.